Cargando…
Dabigatran approaching the realm of heparin-induced thrombocytopenia
Heparin-induced thrombocytopenia (HIT) is a serious, immune mediated complication of exposure to unfractionated or low-molecular-weight heparin. Though rare, it is a condition associated with high morbidity and mortality that requires immediate change to alternative anticoagulants for the prevention...
Autores principales: | Ho, Patricia J, Siordia, Juan A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931941/ https://www.ncbi.nlm.nih.gov/pubmed/27382551 http://dx.doi.org/10.5045/br.2016.51.2.77 |
Ejemplares similares
-
Simultaneous Pancreas-Kidney Transplantation in a Patient with Heparin-Induced Thrombocytopenia on Dabigatran Therapy
por: Jóźwik, Agnieszka, et al.
Publicado: (2018) -
Dabigatran, a direct thrombin inhibitor, can be a life-saving treatment in
heparin-induced thrombocytopenia
por: Mirdamadi, Ahmad
Publicado: (2013) -
Heparin-induced thrombocytopenia: an update
por: Franchini, Massimo
Publicado: (2005) -
Autoimmune Heparin-Induced Thrombocytopenia
por: Warkentin, Theodore E.
Publicado: (2023) -
Thrombocytopenia induced by dabigatran: two case reports
por: Kang, Hyun Goo, et al.
Publicado: (2017)